Insights Into the Role of Bmi‐1 Deregulation in Promoting Stemness and Therapy Resistance in Glioblastoma: A Narrative Review
ABSTRACT Background Glioblastoma (GBM) is the most common primary brain tumor in adults and has a median survival of less than 15 months. Advancements in the field of epigenetics have expanded our understanding of cancer biology and helped explain the molecular heterogeneity of these tumors. B‐cell‐...
Saved in:
| Main Authors: | Fatima Shaalan, Nissrine Ballout, Wafaa Takash Chamoun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glioblastoma Multiformе Tumour Stem Cells as Potential Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2019-11-01) -
The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?
by: Francesco Spallotta, et al.
Published: (2024-11-01) -
Molecular biology of the deadliest cancer – glioblastoma: what do we know?
by: Aly Ismailov, et al.
Published: (2025-03-01) -
Tumor stem cells from glioblastoma multiforme
by: Z. N. Nikiforova, et al.
Published: (2016-06-01) -
FDFT1 maintains glioblastoma stem cells through activation of the Akt pathway
by: Hui Mo, et al.
Published: (2024-12-01)